Liquid Biopsy for Personalised Monitoring of Melanoma Patients [ 2017 - 2019 ]

Research Grant

[Cite as]

Researchers: Prof Mel Ziman (Principal investigator) ,  Dr Elin Gray Prof Helen Rizos Prof Michael Millward Prof Nicholas Hayward

Brief description Despite the success of recent melanoma treatments, therapies are effective long term in only a proportion of patients. Here we will progress preliminary findings in collaboration with biotechnology and pathology companies to develop highly effective companion biomarkers that will aid treatment decisions throughout disease course. Our team will spearhead translation of these markers into the clinic for routine monitoring of melanoma patients.

Funding Amount $AUD 839,817.88

Funding Scheme Development Grants

Notes Development Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]